Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mickael Hiligsmann

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|August 13, 2025
Preference research is underutilized in health preventionBrett Hauber, Mickael Hiligsmann
Expert Review of Pharmacoeconomics & Outcomes Research|September 2, 2017
The projected public health and economic impact of vitamin D fortified dairy products for fracture prevention in FranceMickael Hiligsmann, Jean-Yves Reginster
Expert Review of Pharmacoeconomics & Outcomes Research|July 24, 2025
The economic benefits of fracture preventionLakshmi Nagendra, Manju Chandran, Mickael Hiligsmann
Therapeutic Innovation & Regulatory Science|January 3, 2024
Pediatric Market Access: A Qualitative StudyLieke Maas, Angelika Joos, Mickael Hiligsmann
Journal of Managed Care & Specialty Pharmacy|February 28, 2020
The Value of a Patient-Level Modeling Approach and Need for Better Reporting in Economic Evaluations of OsteoporosisMickael Hiligsmann, Jean-Yves Reginster, Stuart Silverman
Frontiers in Medical Technology|January 20, 2022
A Digital Innovation for the Personalized Management of Adherence: Analysis of Strengths, Weaknesses, Opportunities, and ThreatsAnna-Elisa Hein, Bernard Vrijens, Mickael Hiligsmann
Expert Review of Pharmacoeconomics & Outcomes Research|August 14, 2024
Burden of non-motor symptoms of Parkinson's disease: cost-of-illness and quality-of-life estimates through a scoping reviewFrank van der Meer, Jesper Jorgensen, Mickael Hiligsmann
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 21, 2012
Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic womenMickael Hiligsmann, Wafa Ben Sedrine, Jean-Yves Reginster
Expert Review of Pharmacoeconomics & Outcomes Research|September 20, 2023
Burden of osteoarthritis in the Netherlands: a scoping reviewCharlotte Beaudart, Nannan Li, Annelies Boonen, et al.
BMJ Open|July 10, 2026
Patient preferences for treatment attributes in osteoarthritis: protocol for a systematic review of stated preference studiesMin Liu, Tara Officer, Mickael Hiligsmann, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Expert Review of Pharmacoeconomics & Outcomes Research|August 13, 2025
Preference research is underutilized in health preventionBrett Hauber, Mickael Hiligsmann
Expert Review of Pharmacoeconomics & Outcomes Research|September 2, 2017
The projected public health and economic impact of vitamin D fortified dairy products for fracture prevention in FranceMickael Hiligsmann, Jean-Yves Reginster
Expert Review of Pharmacoeconomics & Outcomes Research|July 24, 2025
The economic benefits of fracture preventionLakshmi Nagendra, Manju Chandran, Mickael Hiligsmann
Therapeutic Innovation & Regulatory Science|January 3, 2024
Pediatric Market Access: A Qualitative StudyLieke Maas, Angelika Joos, Mickael Hiligsmann
Journal of Managed Care & Specialty Pharmacy|February 28, 2020
The Value of a Patient-Level Modeling Approach and Need for Better Reporting in Economic Evaluations of OsteoporosisMickael Hiligsmann, Jean-Yves Reginster, Stuart Silverman
Frontiers in Medical Technology|January 20, 2022
A Digital Innovation for the Personalized Management of Adherence: Analysis of Strengths, Weaknesses, Opportunities, and ThreatsAnna-Elisa Hein, Bernard Vrijens, Mickael Hiligsmann
Expert Review of Pharmacoeconomics & Outcomes Research|August 14, 2024
Burden of non-motor symptoms of Parkinson's disease: cost-of-illness and quality-of-life estimates through a scoping reviewFrank van der Meer, Jesper Jorgensen, Mickael Hiligsmann
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 21, 2012
Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic womenMickael Hiligsmann, Wafa Ben Sedrine, Jean-Yves Reginster
Expert Review of Pharmacoeconomics & Outcomes Research|September 20, 2023
Burden of osteoarthritis in the Netherlands: a scoping reviewCharlotte Beaudart, Nannan Li, Annelies Boonen, et al.
BMJ Open|July 10, 2026
Patient preferences for treatment attributes in osteoarthritis: protocol for a systematic review of stated preference studiesMin Liu, Tara Officer, Mickael Hiligsmann, et al.
Pageof 9